Press Releases

11/30/2005
Labopharm Submits NDA for Once-Daily Tramadol

11/17/2005
Labopharm's Once-Daily Tramadol Product Launched in Germany

11/16/2005
Labopharm Enters Into UK Distribution Agreement with Recordati for Once-Daily Tramadol

11/3/2005
Labopharm Removes Uncertainty Related to Commercialization of its Once-Daily Tramadol in the U.S.

11/2/2005
Labopharm to present at CIBC World Markets Sixteenth Annual Healthcare Conference in New York

11/1/2005
Labopharm Completes Licensing Agreement for Once-Daily Tramadol with Purdue Pharma

10/27/2005
Labopharm Reports Results for Third Quarter Fiscal 2005

10/25/2005
Labopharm Announces Resignation of Ian Lennox from Board of Directors

10/19/2005
Labopharm To Host Conference Call Thursday, October 27, 2005 At 8:30 A.M. (ET)

10/3/2005
Labopharm Partners with GlaxoSmithKline to Commercialize Once-Daily Tramadol in Latin America

9/22/2005
Labopharm to present at UBS Global Life Sciences Conference in New York

9/6/2005
Labopharm Receives Regulatory Approval of Once-Daily Tramadol for 22 European Countries

8/25/2005
Labopharm appoints interim Chairman

8/15/2005
Update - Labopharm Inc. - Special Announcement Webcast - August 15, 2005

8/15/2005
Labopharm and Purdue Pharma Enter U.S. Licensing and Distribution Agreement for Once-Daily Tramadol

7/28/2005
Update - Labopharm Inc. - Q2 Earnings Announcement Webcast - July 28, 2005

7/28/2005
Labopharm annonce un changement d'heure pour la conférence téléphonique afin de discuter des résultats du deuxième trimestre à 16 h 30 (HAE) (jeudi, le 28 juillet 2005)

7/28/2005
Labopharm changes time of second quarter conference call to 4:30pm (ET) today (Thursday, July 28, 2005)

7/28/2005
Labopharm reports results for second quarter fiscal 2005

7/27/2005
Labopharm Inc. - Q2 Earnings Announcement Webcast - July 28, 2005

7/26/2005
Labopharm to present at the Banc of America Securities 2005 Specialty Pharmaceuticals Conference in Southampton, New York

7/14/2005
Labopharm To Host Conference Call Thursday, July 28, 2005 At 8:30 A.M. (ET)

6/29/2005
Labopharm enters into agreement for US$10 million debt financing

6/15/2005
Labopharm announces webcast of Analyst Day presentations

6/9/2005
Labopharm to present at Merrill Lynch 12th Annual Growth Stock Conference in Toronto

5/17/2005
Labopharm to present at Banc of America Securities and UBS Conferences

5/5/2005
Labopharm reports financial results for first quarter of 2005

5/2/2005
Labopharm changes time of first quarter conference call to 4:00pm (ET) Thursday May 5, 2005

4/22/2005
Labopharm To Host Conference Call Thursday, May 5, 2005 At 8:30 A.M. (ET)

4/20/2005
Labopharm Inc. - Annual General Meeting - April 20, 2005

4/13/2005
Labopharm announces details of 2005 Annual Meeting

4/4/2005
Labopharm to present at CIBC World Markets Conference in New York

3/8/2005
Labopharm Initiates Regulatory Approval Process in Mexico for Once-Daily Tramadol

3/3/2005
Labopharm Adds Russia to Distribution and Licensing Agreement with CSC Pharma for Once-Daily Tramadol

2/17/2005
Labopharm Inc. - Fiscal 2004 Fourth Quarter and Year End Financial Results - February 17, 2005

2/17/2005
Labopharm reports results for fourth quarter and year end fiscal 2004

2/16/2005
Labopharm Inc. - Fiscal 2004 Fourth Quarter and Year End Financial Results - February 17, 2005

2/7/2005
Labopharm To Host Conference Call Thursday, February 17, 2005 At 8:30 A.M. (ET)

2/2/2005
Labopharm to present at Merrill Lynch Conference in New York

1/17/2005
Labopharm receives notification of regulatory approval in France for once-daily tramadol

1/17/2005
Labopharm receives notification of regulatory approval in France for once-daily tramadol